NCT01541709 2024-01-02
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
Phase 2 Unknown
Clinical Trials
10 trialsNCT02365441 2023-07-07
ALT GIST
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
NCT03139487 2020-01-06
PRIORITY
Asan Medical Center
Phase 2 Unknown
NCT04106024 2019-09-26
Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial
Cttq
Phase 2 Unknown
NCT02336724 2018-04-17
A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT02982486 2017-11-01
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT03171389 2017-05-31
POETIG
Universität Duisburg-Essen
Phase 2 Unknown
NCT02426762 2015-08-13
Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery
First Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT01389583 2015-02-25
A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT00290485 2006-04-07
Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
Maisonneuve-Rosemont Hospital
Phase 2 Unknown